BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29778900)

  • 21. Serine restriction alters sphingolipid diversity to constrain tumour growth.
    Muthusamy T; Cordes T; Handzlik MK; You L; Lim EW; Gengatharan J; Pinto AFM; Badur MG; Kolar MJ; Wallace M; Saghatelian A; Metallo CM
    Nature; 2020 Oct; 586(7831):790-795. PubMed ID: 32788725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial protein alterations in a familial peripheral neuropathy caused by the V144D amino acid mutation in the sphingolipid protein, SPTLC1.
    Stimpson SE; Coorssen JR; Myers SJ
    J Chem Biol; 2015 Jan; 8(1):25-35. PubMed ID: 25584079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
    McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
    Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.
    Bejaoui K; Uchida Y; Yasuda S; Ho M; Nishijima M; Brown RH; Holleran WM; Hanada K
    J Clin Invest; 2002 Nov; 110(9):1301-8. PubMed ID: 12417569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase.
    Gable K; Han G; Monaghan E; Bacikova D; Natarajan M; Williams R; Dunn TM
    J Biol Chem; 2002 Mar; 277(12):10194-200. PubMed ID: 11781309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
    Othman A; Benghozi R; Alecu I; Wei Y; Niesor E; von Eckardstein A; Hornemann T
    J Clin Lipidol; 2015; 9(4):568-75. PubMed ID: 26228675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
    Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of 1-Deoxysphingolipids in docetaxel neurotoxicity.
    Becker KA; Uerschels AK; Goins L; Doolen S; McQuerry KJ; Bielawski J; Sure U; Bieberich E; Taylor BK; Gulbins E; Spassieva SD
    J Neurochem; 2020 Sep; 154(6):662-672. PubMed ID: 32058598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma.
    Duan J; Merrill AH
    J Biol Chem; 2015 Jun; 290(25):15380-15389. PubMed ID: 25947379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts.
    Karsai G; Steiner R; Kaech A; Lone MA; von Eckardstein A; Hornemann T
    J Lipid Res; 2021; 62():100122. PubMed ID: 34563520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells.
    Dedov VN; Dedova IV; Merrill AH; Nicholson GA
    Biochim Biophys Acta; 2004 Mar; 1688(2):168-75. PubMed ID: 14990347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype.
    Auer-Grumbach M; Bode H; Pieber TR; Schabhüttl M; Fischer D; Seidl R; Graf E; Wieland T; Schuh R; Vacariu G; Grill F; Timmerman V; Strom TM; Hornemann T
    Eur J Med Genet; 2013 May; 56(5):266-9. PubMed ID: 23454272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx.
    Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S
    J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Dietary Fat Consumption Impairs Axonal Mitochondrial Function
    Sajic M; Rumora AE; Kanhai AA; Dentoni G; Varatharajah S; Casey C; Brown RDR; Peters F; Hinder LM; Savelieff MG; Feldman EL; Smith KJ
    J Neurosci; 2021 May; 41(19):4321-4334. PubMed ID: 33785643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary sensory and autonomic neuropathy type IC accompanied by upper motor neuron abnormalities and type II juxtafoveal retinal telangiectasias.
    Triplett J; Nicholson G; Sue C; Hornemann T; Yiannikas C
    J Peripher Nerv Syst; 2019 Jun; 24(2):224-229. PubMed ID: 30866134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
    Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
    J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serine palmitoyltransferase assembles at ER-mitochondria contact sites.
    Aaltonen MJ; Alecu I; König T; Bennett SA; Shoubridge EA
    Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34785538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensory neuropathy-causing mutations in ATL3 affect ER-mitochondria contact sites and impair axonal mitochondrial distribution.
    Krols M; Asselbergh B; De Rycke R; De Winter V; Seyer A; Müller FJ; Kurth I; Bultynck G; Timmerman V; Janssens S
    Hum Mol Genet; 2019 Feb; 28(4):615-627. PubMed ID: 30339187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.
    Alecu I; Othman A; Penno A; Saied EM; Arenz C; von Eckardstein A; Hornemann T
    J Lipid Res; 2017 Jan; 58(1):60-71. PubMed ID: 27872144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.